Two Minimal Clinically Important Difference (2MCID): A New Twist on an Old Concept
Main Authors: | Faraz M. Ali, M. Sam Salek, Andrew Y. Finlay |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Journals Sweden
2018-04-01
|
Series: | Acta Dermato-Venereologica |
Online Access: |
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-2894
|
Similar Items
-
Minimal clinically important difference (MCID) in patient-reported outcome measures for neurological conditions: Review of concept and methods
by: Biswamohan Mishra, et al.
Published: (2023-01-01) -
Meaningful benefit and minimal clinically important difference (MCID) in Alzheimer's disease: Open peer commentary
by: Jeffrey Cummings
Published: (2023-07-01) -
1120 Determination of the minimal clinically important difference (MCID) of the physician global assessment (PGA) in SLE
by: Meggan Mackay, et al.
Published: (2021-11-01) -
Precision in treatment evaluation: importance of minimal clinically important differences (MCIDs) of outcome measures for autoimmune blistering diseases
by: Henry Tseng, et al.
Published: (2023-09-01) -
Minimal Clinically Important Difference (MCID) in the Functional Status Measures in Patients with Stroke: Inverse Probability Treatment Weighting
by: Yu-Chien Chang, et al.
Published: (2023-09-01)